← Back to Search

Terbinafine Tablets for Psoriatic Spondylitis (FUN Trial)

Phase < 1
Waitlist Available
Led By Atul Deodhar, M.D.
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

FUN Trial Summary

This trial will help researchers understand if a certain anti-fungal drug could help treat patients with a certain type of arthritis.

Eligible Conditions
  • Psoriatic Spondylitis
  • Epidural Block
  • Ankylosing Spondylitis
  • Spondylitis

FUN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BASDAI score

FUN Trial Design

2Treatment groups
Active Control
Group I: Placebo to DrugActive Control2 Interventions
Subjects will begin treatment on placebo then crossover to study drug.
Group II: Drug to PlaceboActive Control2 Interventions
Subjects will begin treatment on study drug then crossover to placebo.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
966 Previous Clinical Trials
6,845,751 Total Patients Enrolled
The Malassezia FoundationUNKNOWN
Atul Deodhar, M.D.Principal InvestigatorOregon Health and Science University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any antecedent investigations that have examined this treatment's efficacy?

"Presently, there are 3 independent clinical trials exploring this intervention. None of the live studies have reached Phase 3 yet. These investigations are primarily based in Portland, Oregon but encompass 7 distinct trial sites."

Answered by AI

What conditions are typically addressed by this curative regimen?

"This therapeutic intervention is typically prescribed to treat onychomycosis. Additionally, it can be utilized in the management of tinea cruris, severe tinea pedis and sporotrichosis."

Answered by AI

How many subjects are being recruited for this research trial?

"Affirmative. Clinicaltrials.gov's records demonstrate that this medical study, which was initially posted on March 9th 2021, is actively seeking participants. Approximately 20 individuals need to be recruited from 1 research facility."

Answered by AI

Is the enrollment period for this trial still ongoing?

"According to the clinicaltrials.gov database, the study is still accruing participants with its posting date being March 9th 2021 and most recent update on November 3rd 2021."

Answered by AI
Recent research and studies
~0 spots leftby Mar 2025